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Abstract Mastitis, inflammation of the mammary gland,
can be caused by a wide range of organisms, including
gram-negative and gram-positive bacteria, mycoplasmas
and algae. Many microbial species that are common causes
of bovine mastitis, such as Escherichia coli, Klebsiella
pneumoniae, Streptococcus agalactiae and Staphylococcus
aureus also occur as commensals or pathogens of humans
whereas other causative species, such as Streptococcus
uberis, Streptococcus dysgalactiae subsp. dysgalactiae or
Staphylococcus chromogenes, are almost exclusively found
in animals. Awide range of molecular typing methods have
been used in the past two decades to investigate the
epidemiology of bovine mastitis at the subspecies level.
These include comparative typing methods that are based
on electrophoretic banding patterns, library typing methods
that are based on the sequence of selected genes, virulence
gene arrays and whole genome sequencing projects. The
strain distribution of mastitis pathogens has been investi-
gated within individual animals and across animals, herds,
countries and host species, with consideration of the
mammary gland, other animal or human body sites, and
environmental sources. Molecular epidemiological studies
have contributed considerably to our understanding of
sources, transmission routes, and prognosis for many
bovine mastitis pathogens and to our understanding of
mechanisms of host-adaptation and disease causation. In
this review, we summarize knowledge gleaned from two
decades of molecular epidemiological studies of mastitis
pathogens in dairy cattle and discuss aspects of comparative
relevance to human medicine.
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Introduction
Over the past two decades, a wide range of phenotyping
and genotyping methods have been developed or imple-
mented to study mastitis-causing bacteria of dairy cattle at
the species and subspecies level. Genotyping methods used
to characterize bovine mastitis-causing pathogens range
from simple restriction digest or PCR based approaches to
micro-arrays and whole genome sequencing. It is beyond
the scope of this paper to explain technical aspects,
strengths and weaknesses of all molecular methods used
for typing of bovine mastitis pathogens. The reader is
referred to guidelines for the validation and application of
typing methods for use in bacterial epidemiology for
technical aspects [180, 189, 194] and to a review of use
of molecular epidemiology in veterinary practice for
applications and interpretations [212]. The focus of our
paper is “molecular epidemiology”, which we interpret as
the use of DNA-based characterization of micro-organisms
at the subspecies level to understand their sources,
transmission routes, biological relationships, and virulence
characteristics. Molecular diagnostics at the species level
will not be covered in depth, unless the state of the art for a
particular species has not progressed much beyond that
stage. Molecular determinants of antimicrobial resistance
are beyond the scope of this review.
The main bovine mastitis pathogens that have been
investigated using molecular methods are the gram-negative
species Escherichia coli and Klebsiella pneumoniae and the
gram-positive species Streptococcus agalactiae, Streptococcus
uberis,a n dStaphylococcus aureus. Most of these organisms
also occur as commensals or pathogens of humans. Develop-
ment of molecular methods for use in human medicine has
facilitated studies of these organisms in the context of bovine
mastitis. For other species or genera, such as Streptococcus
dysgalactiae subsp. dysgalactiae, coagulase negative staphy-
lococci (CoNS) or Mycoplasma spp., molecular typing at the
subspecies level is still in its infancy. At the forefront of
molecular epidemiological research, large scale studies using
library typing methods and on-line databases such as multi-
locus sequence typing (MLST) demonstrate host-adaptation
of major pathogens of cattle and humans, whilst virulence
gene arrays and whole genome sequencing shed light on
mechanisms of pathogen evolution and adaptation to the
bovine host or the mammary gland. Meanwhile, comparative
typing methods based on electrophoretic banding patterns are
increasingly used in veterinary diagnostic laboratories, bring-
ing the use of molecular epidemiology for outbreak- and
farm-investigations within reach of dairy veterinarians and
farm advisors.
The aim of this review is to summarize knowledge
gleaned from two decades of molecular epidemiological
studies of mastitis pathogens in dairy cattle, reflecting the
breadth of coverage and depth of knowledge available for
the different pathogen species. For each species or genus,
major research questions, results and insights will be
summarized, starting with gram-negative pathogens, fol-
lowed by gram-positive pathogens, and ending with algae
and mycoplasmas. Animal- and herd-level studies as well
as studies spanning a wide spatiotemporal scale or multiple
host species are considered. Where relevant, comparative
aspects of human medicine will be discussed.
E. coli Mastitis
Escherichia coli is a common cause of intramammary
infection in dairy cattle. Infection usually manifests with
clinical signs. Based on epidemiological data and early strain
typing studies, which showed large heterogeneity among
isolates associated with cases of mastitis within farms, [103,
109, 133], E. coli is classified as an opportunistic environ-
mental pathogen. There are no specific virulence factors that
differentiate strains with the ability to cause mastitis from
other E. coli strains [12, 183, 206]. The severity of clinical
signs, which may range from mild to fatal, is largely
attributed to host-characteristics [29].
Most cases of E. coli mastitis are transient and end with
death of either the host or the pathogen. However, recurrent
cases of clinical E. coli mastitis were recognized in early
strain typing studies [103, 109]. Recurrent cases could be
due to repeated episodes of infection and cure, or to
persistent infection with alternating subclinical and clinical
episodes. Considering the heterogeneity of environmental
E. coli, repeated episodes of infection would be expected to
be caused by different strains. Such repeated episodes could
be due to chance or to increased host-level or quarter-level
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intramammary infection would have to be caused by a
single strain that was present for a long time, resulting in
repeated isolation of the same strain from multiple clinical
episodes. In an initial study of 7 herds, persistent E. coli
infections, characterized by repeated isolation of the same
random amplified polymorphic DNA (RAPD) type from
multiple clinical episodes, were described as “sporadic”
[103, 109]. In a subsequent study of 300 herds, 11% of
cows had recurrent clinical cases of E. coli mastitis [43].
Half of the recurrent cases occurred in the same mammary
quarter as the initial case, and half of the recurrent cases
within a mammary quarter were due to the same strain as
the initial case. This shows that both scenarios, i.e. repeated
infections and persistent infection, do indeed occur. When
recurrent cases occurred in a different quarter than the
initial episode, strains were still the same for approximately
28% of quarters, suggesting that within-cow transmission
of E. coli may occur [43]. Whether apparent transmission
occurs via direct or indirect contact between teats or results
from concurrent exposure is unknown. Systemic dissemi-
nation is unlikely, because cows with systemic E. coli
infection tend to be very sick, whereas cows with recurrent
clinical episodes generally show relatively mild symptoms
[206]. In 6 dairy herds in England, Bradley and Green [22]
observed the same phenomena as described by Döpfer and
colleagues [43], albeit at different frequencies. In their
study, the same strain of E. coli accounted for 86% of
recurrent cases within a quarter, but only 8.5% of recurrent
cases in different quarters of the same animal [22]. In both
studies, strain typing was based on use of enterobacterial
repetitive intergenic consensus (ERIC) sequence primers
[22, 43]. Therefore, differences in results are likely to be
due to herd selection rather than typing methods.
The high incidence of clinical E. coli mastitis in early
lactation has been attributed to increased host susceptibility
at that time [29]. Using ERIC-typing, however, many
clinical episodes of E. coli mastitis in early lactation could
be traced back to infections that originated in the preceding
non-lactating period rather than the lactating period [21].
This discovery led to evaluation of antimicrobial products
with a gram-negative spectrum for treatment and prevention
of mastitis during the non-lactating period. Use of such a
product reduced the incidence of clinical E. coli mastitis
during the non-lactating period as well as the first 100 days
of the following lactation [23]. This is a nice example of
molecular studies leading to increased understanding of the
epidemiology and pathogenesis of mastitis or even “shatter-
ing a paradigm”, and subsequent development of interven-
tions targeting the newly understood or rediscovered
biological mechanisms. Although it has been suggested
that the occurrence of persistent E. coli infections may be
due to host-adaptation of the pathogen [22], persistent E.
coli infections with recurrent clinical signs were already
described in the 1970s [84]. Molecular typing methods
were not available at the time, but serology was used to
demonstrate that repeated clinical episodes were due to the
same serotype of E. coli. Whether the incidence of
persistent infections with recurrent clinical episodes has
increased, or whether our awareness has increased is
difficult to ascertain with available data.
Despite clear differences in phenotypic traits in vitro,
particularlywithregardstoinvasionandsurvivalinmammary
epithelial cells [3, 44], no clear genetic differences have been
identified between E. coli strains from transient or persistent
infections [42, 183]. Phenotypic differences have also been
described between E. coli isolates from cows with clinical
mastitis and the farm environment of those cows [18]. The
two groups of isolates differed in average lactose fermenta-
tion and growth in milk (both were higher in mastitis
isolates) and in phagocytosis by bovine polymorphonuclear
neutrophils, which are considered to be the first line of
defense against coliform mastitis (lower for mastitis isolates;
[18]). In addition to phenotypic differences, clustering of
pulsed-field gel electrophoresis (PFGE) types within catego-
ries (mastitis or environmental) was described [18]. It is
difficult to infer phylogeny from PFGE data, or to reconcile
the data from Blum and coworkers with those from other
studies. So far, all methods used for E. coli typing have
targeted pre-selected elements of the genome only, e.g.
virulence or antimicrobial resistance genes, restriction sites,
or primer binding sites. Whole genome sequencing of
transient and persistent E. coli strains is in progress and
may shed new light on possible mechanisms of host
adaptation in mastitis-causing E. coli.
Klebsiella Mastitis
The most common Klebsiella species causing bovine
mastitis are K. pneumoniae and K. oxytoca. Molecular
methods, specifically sequencing of the rpoB gene, recently
showed that some isolates with the phenotypic appearance
of K. pneumoniae or K. oxytoca belong to the closely
related genus Raoultella.B o t hR. terrigena and R.
planticola can be found in the dairy farm environment,
and R. planticola has also been isolated from milk [129,
220]. Most molecular epidemiological studies of Klebsiella
focus on assessment of heterogeneity of K. pneumoniae
within samples or herds, or on comparison of isolates
obtained from animals and their environment to identify
Klebsiella sources and transmission routes.
Analysis of Klebsiella populations within individual
milk samples has yielded conflicting results. Paulin-Curlee
and colleagues [141] characterized 3 isolates for each of 26
milk samples and found a single repetitive DNA sequence
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rep-PCR types in 36% of samples and 3 rep-PCR types in
18% of samples. By contrast, Munoz and coworkers [129]
characterized 4 isolates for each of 14 milk samples and
consistently found a single RAPD-type per sample. Milk
samples in the first study originated from a privately-owned
dairy herd and were mailed to a diagnostic laboratory.
Details on sample collection procedures are not given. Milk
samples in the second study were collected by trained field
personnel from a different diagnostic laboratory, using
aseptic technique. The number of strains per sample may
differ between herds if they are sampled by different people
[142]. Given that Klebsiella is very common on teat skin of
dairy cattle [130], sample collection methods may play a
role in heterogeneity of Klebsiella in milk samples. The
observed strain heterogeneity may also be affected by the
discriminatory power of the typing method, which differs
between methods, or even between primer sets used for a
single method, such as RAPD-typing [128]. It has been
suggested that the discriminatory power of rep-PCR, PFGE
and MLST increases in that order for K. pneumoniae,b u t
values for Simpson’s index of discrimination, a standard
measure of discriminatory power [180], were not based on
analysis of the same collection of isolates with each method
but rather on nested subsets of isolates [142]. This may have
affected the apparent discriminatory power of the methods.
In samples from bovine feces, the rumen, drinking water
and the farm environment, within-sample heterogeneity is
common [129]. Based on characterization of 4 isolates per
fecal sample using RAPD-typing, the median number of
strains per sample was estimated at 3 [128]. With
characterization of 5 isolates per fecal or rumen sample
and using the same method, the median number of strains
per sample was estimated at 4 [220]. This illustrates that the
number of strains found is a function of the number of
isolates processed, which tends to be a function of the
budget for a particular study. If it is assumed that a fecal
sample contains 4 strains in equal numbers, as many as 15
isolates need to be characterized to be 95% certain that all
strains will be detected [45]. Considering the heterogeneity
of strains in cows, their feces and the farm environment, it
can be difficult to determine the origin of a mastitis-causing
strain or, conversely, the mastitis-causing potential of
strains from extra mammary sources. Wood-based bedding
is often cited as a source of Klebsiella and has been
implicated in mastitis outbreaks based on culture results
[134, 167]. In a study of 6 Belgian herds, Verbist and
colleagues [199] characterized isolates at the sub-species
level to assess whether Klebsiella from feces or sawdust
could be identified as the cause of mastitis. Among 120
fecal K. pneumoniae isolates, 88 PFGE patterns were
identified. None of these patterns were associated with
clinical mastitis during the study. In unused bedding
material, 5 isolates were detected, each with a unique
PFGE pattern. Again, none of these patterns were associ-
ated with clinical mastitis during the study. In another
attempt to match Klebsiella from sawdust with mastitis
cases, only Raoultella was found in unused bedding [129].
Used bedding material, however, has been identified as a
possible source of infection. It is thought that presence of
Klebsiella in used bedding is due to contamination with
bovine feces or with milk from Klebsiella infected cows
[129, 199].
As for E. coli, the heterogeneity of Klebsiella strains in
the environment is reflected by strain heterogeneity among
infected cows within a herd [99, 129, 141, 142]. Even so,
strains affecting multiple cows have been observed in
several herds [99, 129, 142]. Possible explanations include
lack of discriminatory power of typing methods, cow-to-
cow transmission, exposure to a point source, or increased
fitness of specific strains [212]. Lack of discriminatory
power is difficult to exclude, although multiple methods
were used in the studies cited (plasmid profiling, rep-PCR
and RAPD-typing) and each method identified within-farm
heterogeneity. Attempts to demonstrate cow-to-cow trans-
mission via the milking machine, which is the usual mode
of transmission for mastitis pathogens, appeared promising
based on culture results. Molecular typing, however,
showed that apparent transmission was caused by contam-
ination of the milking machine with different strains of
Klebsiella by different cows, possibly from teat skin [129,
130]. Excretion of milk by an infected cow, resulting in
seeding of bedding with a large number of colonies from a
single strain, was considered the most likely explanation for
the observations and was tentatively called “cow-to-cow
transmission via the environment” [129]. To date, markers
of increased fitness, i.e. enhanced ability to cause mastitis,
have not been published for Klebsiella strains.
Other Gram-Negative Pathogens
Non-coliform gram-negative species may occasionally
cause severe mastitis problems. Pseudomonas aeruginosa
has been associated with mono- or polymicrobial breast
abscesses and septic mastitis in women [74, 126] and with
mastitis in cattle, sheep and goats [173]. Outbreaks of P.
aeruginosa mastitis in dairy cattle have been reported from
Australia [119], Ireland [34], Israel [173] and The Nether-
lands [177], often with a high fatality rate. Based on PFGE,
a large variety of P. aeruginosa strains may cause mastitis
in sheep, goats and cattle, without evidence of clonality
within herds [173]. In one case, clonality was suggested
based on exposure to a common risk factor: all herds
involved in the Dutch multi-herd P. aeruginosa mastitis
outbreak used the same disinfectant wipes [177]. Such
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intramammary antimicrobial treatment via the teat opening.
Strain typing data were not generated to test the hypothesis
of clonality of this outbreak. A similar multi-herd outbreak,
associated with the same brand of disinfectant wipes,
occurred in Ireland [34]. Molecular epidemiological inves-
tigations demonstrated that all herds were affected by the
same strain of P. aeruginosa. Initially, this result was
obtained using ribotyping with the restriction enzyme ClaI.
Comparison with epidemiologically unrelated human iso-
lates from hospitals demonstrated that the same ClaI
ribotype could also be found in humans, suggesting that
lack of discriminatory power might explain the observed
strain homogeneity. Subsequent ribotyping with PvuII
proved more discriminatory, with only the mastitis isolates
showing identical patterns. The outbreak strain was also
isolated from an unused container of the suspect disinfec-
tant wipes, confirming that they were the likely source of
the outbreak. Without molecular typing, identification of a
common risk factor should not be interpreted as evidence of
that risk factor being the source of the outbreak. This was
demonstrated in a multi-state outbreak of Serratia mastitis
[127]. In this outbreak, as in the Dutch P. aeruginosa
outbreak, a common risk factor was identified across herds,
i.e. use of a chlorhexidine based teat dip. In contrast with
the P. aeruginosa outbreak, isolates from the Serratia
outbreak did not belong to a single strain type. Based on
RAPD-typing, Serratia isolates from different farms
belonged to different strains, showing that the suspect
product had been contaminated on the individual farms.
Within each farm, animals were usually infected with a
single strain of S. marcescens (Fig. 1) and the same strain
was found in teat dip on some farms. This shows that the teat
dip may have acted as a point source or a fomite for
transmission. In other herds, multiple S. marcescens strains
or multiple Serratia species were identified, demonstrating
that Serratia mastitis can also result from exposure to a
variety of environmental strains of the pathogen. In hospitals,
as on farms, outbreaks of Serratia infection are occasionally
linked to contaminated chlorhexidine based on bacteriology
and molecular typing [115, 200]. Serratia mastitis is very
rare in humans, but a case was recently described in
association with a contaminated breast pump [54].
Streptococcus agalactiae
In humans, Strep. agalactiae or group B streptococcus
(GBS) is associated with early and late onset disease in
infants, with asymptomatic colonization of the urogenital
and gastro-intestinal tract, and with septicemia and other
clinical manifestations in non-pregnant adults [94, 105]. In
women, Strep. agalactiae may cause breast abscess
formation and clinical or asymptomatic mastitis [159].
Maternal mastitis is a risk factor for late onset Strep.
agalactiae disease in infants [38, 138, 201]. When
molecular typing of Strep. agalactiae from mother-baby
pairs is performed, isolates within pairs are indistinguish-
able but distinct from those of other pairs, confirming
mother-child relationships [15, 37, 100]. In cattle, mastitis
is the only disease associated with Strep. agalactiae
infection. Transmission within herds is thought to be
strictly contagious, i.e. from cow to cow, due to insufficient
hygiene in the milking parlor, allowing multiple animals to
come into contact with equipment, hands or towels that are
contaminated by milk from an infected cow ([97, 132]).
This mode of transmission results in the presence of a
single strain in multiple animals in a herd [11, 37, 47, 120,
136, 179, 203]. The observed strain homogeneity is not due
to lack of discriminatory power, because the same techni-
ques have demonstrated differences between isolates from
different farms or host species, including humans, cattle and
fish [11, 47, 143]. Because herd-level mastitis problems are
generally easily and cost-effectively resolved through
implementation of herd hygiene and treatment programs
[49, 52], few molecular epidemiological studies of persis-
tence, transmission routes or sources of infection have been
conducted in cattle.
The major question in molecular epidemiology of bovine
Strep. agalactiae is whether it constitutes a human health
hazard, either through direct transmission between cattle
and humans [26, 112] or through evolution of human-
pathogenic strains from a bovine reservoir [16]. Conversely,
others have suggested that humans may act as a source of
infection for cattle [41, 212], a mechanism that has also
been proposed for dogs, cats and crocodiles [17, 210].
Experiments to assess the pathogenic potential of human
Strep. agalactiae in cattle were already conducted in the
Figure 1 Random amplified polymorphic DNA profiles of Serratia
marcescens isolates from two dairy herds (indicated by lines). Lanes 1
and 16 contain molecular markers (MM); Lanes 2 and 10 represent
teat dip isolates (TD); Lanes 3 through 9 and 11 through 15 represent
isolates from composite cow milk samples. Within-herd homogeneity
and between-herd heterogeneity are seen
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of lactating quarters with human Strep. agalactiae resulted in
clinical mastitis, but human strains showed a pronounced
tendency to spontaneously clear [92, 196]. In contrast, bovine
strains caused chronic subclinical infection, enhancing the
probability of subsequent spread within the herd [92]. The
first large-scale molecular comparison of human and bovine
Strep. agalactiae populations was based on RAPD-typing.
The majority of bovine isolates were contained in major
RAPD clusters that consisted exclusively of bovine isolates
but some clusters included a mixture of bovine and human
isolates [113]. Subsequent comparisons using other methods,
such as ribotyping, PFGE and molecular serotyping sup-
ported the notion that human and bovine Strep. agalactiae are
largely distinct populations [41, 48, 181, 222]. The distinction
is not always absolute. For example, virulence genes such as
the C5a peptidase gene spcB and the laminin binding gene
lmb are present in almost all human isolates and in 20 to 44%
of bovine isolates [27, 64, 179, 210].
When MLST was developed for Strep. agalactiae, strain
typing information could be used to investigate population
biology and pathogen evolution [93]. MLST based group-
ing did not correspond to grouping of strains based on
RAPD or serotyping [19, 20, 27], but an association
between sequence types (STs) and host species or clinical
manifestation was identified [16, 53, 93]. The major human
STs (ST1, ST17, ST19 and ST23) were initially associated
with asymptomatic carriage, invasive neonatal disease,
asymptomatic carriage, and a mixture of invasion and
carriage, respectively [93]. Subsequent studies only sup-
ported the association of ST17 with neonatal invasive
disease [20, 94]. Human isolates showed greater diversity
in STs than bovine isolates and clustered separately from
bovine isolates, which were primarily comprised of ST67
and its single locus variant (SLV) ST61 [16]. Given that
many organ systems can be affected by Strep. agalactiae in
humans while only the mammary gland is affected in cattle,
it may not seem surprising that a lower level of genetic
heterogeneity was detected in bovine isolates. It was
suggested that the hyperinvasive human neonatal clone
ST17 had arisen from bovine ST67, to which it is
connected by a chain of 2 SLVs [16]. Despite the relatively
close relationship between ST17 and ST67, use of
additional markers such as insertion sequences and infB
alleles still identified human and bovine isolates as largely
distinct populations [19]. Subsequent studies considered a
much larger part of the genome, either through combination
of an expanded 15-gene MLST scheme, molecular serotyp-
ing and virulence gene screening [179] or by comparative
genomic hybridization [27]. Both studies showed that the
Strep. agalactiae genome has a composite structure due to
recombination, which distorts the phylogenetic signal.
These studies did not support the idea that ST17 had arisen
from a bovine ancestor and reaffirmed that human and
bovine isolates largely form distinct populations [27, 179].
In addition to isolates from clonal complex (CC) 67,
isolates from CC23 are frequently found in bovine mastitis
[19, 27, 73, 179]. ST23 probably has the widest host range
of all Strep. agalactiae STs. It has been found in humans,
cattle, dogs, crocodiles and grey seals [17, 27]. Within
ST23, however, human and bovine specific subpopulations
can be distinguished based on serotyping and the diversity
of infB, sodA and gdh alleles [179]. Other strains that are
primarily associated with humans but have been reported
from cattle include members of CC1, ST8, CC19 and CC26
[27, 73, 112, 136, 179].
Earlier this year, the first complete genome sequence of a
bovine Strep. agalactiae isolate, belonging to ST67, was
published [162]. Comparison with genomes from human
Strep. agalactiae isolates revealed 8 novel genomic islands
that were probably acquired by lateral gene transfer (LGT).
Screening of 20 bovine and 20 human isolates showed that
some of these islands were significantly more common in
bovine than in human isolates. One such island includes
genes from a fructose- and lactose-operon, in agreement
with studies from the pre-molecular era, which described
differences between human and bovine isolates in lactose
utilization [56, 162]. Using 238 isolates from 9 countries
and 5 continents, Sørensen and colleagues [179] demon-
strated that 92% of bovine isolates and 13% of human
isolates ferment lactose. The linked fructose- and lactose-
operons of Strep. agalactiae share 99% sequence homology
with those of Strep. dysgalactiae subsp. dysgalactiae,
another bovine mastitis pathogen. This suggests that LGT
may take place between different pathogen species in the
bovine udder. Similarly, LGT between Strep. agalactiae,
Strep. pyogenes and group C and G streptococci is thought
to have contributed to adaptation to their shared human
niche [64]. Another example of LGT between bovine
mastitis pathogens is provided by the nisin-operon, which
shows close similarity between Strep. agalactiae and Strep.
uberis, a pathogen that is rarely associated with any other
disease or host species [162, 211].
Evolutionary considerations regarding niche adaptation
are important for epidemiological reasons. If bovine Strep.
agalactiae forms a reservoir for emergence of virulent
human clones, an argument could be made for eradication
of bovine Strep. agalactiae [86]. If occurrence of Strep.
agalactiae in predominantly Strep. agalactiae-negative
herds or areas is due to spill-over of human Strep.
agalactiae into the bovine population [41], eradication of
bovine Strep. agalactiae may not be possible or necessary.
Pathogen evolution may also help to explain the re-
emergence of Strep. agalactiae, a phenomenon observed
in Denmark. In the 1950s, Denmark had a herd-level
prevalence of Strep. agalactiae of 20 to 30%. Due to
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approximately 2% by 1979 [91] and it stayed at that level
through the 1980s and ‘90s [4]. Since 2000, a steady
increase in prevalence of Strep. agalactiae has occurred and
in 2008 close to 6% of herds were positive [96]. MLST of
111 isolates from a bulk tank survey conducted in Denmark
in 2009 showed that the most common strains were ST1
(28%) and ST23 (23%), which are STs that were previously
primarily associated with human infection. Members of
CC67 were not detected (RNZ and JK, unpublished;
Fig. 2). The third most common ST was ST103, which
has occasionally been isolated from humans, a cat, a guinea
pig and dairy cattle [20, 27, 73]. It is unknown why or how
ST103 emerged as a highly prevalent clone in bovine milk.
Acquisition of genetic material that confers a survival
advantage in the bovine udder is one of the explanations
under investigation.
Streptococcus uberis
Streptococcus uberis is strictly an animal pathogen [211]
and fewer typing methods are available than for Strep.
agalactiae or Staph. aureus, which are also human
pathogens. Early studies of Strep. uberis used comparative
methods such as RAPD-typing, rep-PCR or PFGE. Later, 2
MLST schemes were developed. The first MLST scheme
encompassed a mixture of housekeeping genes, virulence
genes and vaccine targets [218]. The second MLST scheme
was based on housekeeping genes only [33], although the
status of one of the genes, yqiL, as housekeeping gene has
been cast in doubt due to its absence from some Strep.
uberis strains [193]. An MLVA scheme (Multiple Loci
VNTR Analysis; VNTR, Variable Number of Tandem
Repeats; [66]) has also developed but, like the first MLST
scheme, it has not been applied widely. The genome
sequence of Strep. uberis O140J, a strain often used for
challenge studies [9, 55, 204], was made publicly available
in 2009 [205]. This was quickly followed by whole genome
comparisons of multiple strains using a DNA-microarray
with Strep. uberis O140J as reference strain [104]. The
majority of molecular epidemiological studies on Strep.
uberis focus on sample-, cow- and herd-level strain
heterogeneity with the aim to understand the persistence
and transmission of intramammary infections. More recent-
ly, the focus has shifted to host-adaptation and pathogenesis
studies, taking advantage of the availability of the whole
genome sequence, challenge models and a variety of
“-omics” approaches [108].
DNA-fingerprinting of Strep. uberis was first described
around 1990 [71, 83, 208]. One early study suggested
substantial strain homogeneity among Strep. uberis isolates
[71], which may have been due to the fact that molecular
typing methods were in their infancy and lacked discrim-
inatory power. Since then, almost every study has shown a
considerable level of heterogeneity among strains within
and between herds, whether based on RAPD-typing [67,
90, 217], rep-PCR [207], PFGE [11, 46, 145, 203], or
MLST [151, 193]. In one study, as many as 330 strains
were detected among 343 isolates [46]. Despite the high
level of heterogeneity within herds, an aseptically collected
milk sample from an individual udder quarter usually
contains a single strain of Strep. uberis [137, 145]. Even
after experimental challenge of a mammary quarter with
multiple strains of Strep. uberis, a single strain tends to
become predominant [149]. Within a cow, multiple udder
quarters may be infected with the same strain of Strep.
uberis, which is usually interpreted as an indication of
within-cow transmission [46, 98, 145, 207]. Persistent
infection of a single quarter, resulting in repeated isolation of
the same strain over time, is more common than simultaneous
presenceofa singlestraininmultiplequarters[118]. Infection
of multiple cows within a herd with a single strain has also
been described, and has been attributed to cow-to-cow
transmission [46, 98, 145, 193]. In some herds, up to 50%
to 100% of animals appear to be infected by the same or
closely related strains of Strep. uberis based on RAPD-
typing [67, 217]o rP F G E[ 155]. Strep. uberis infections may
be transient or they may persist over the non-lactating period,
during lactation, or during short-term or extended antimicro-
bial treatment [125, 137, 145, 151, 207, 217]. It is also
possible to find different strains before and after the non-
lactating period [137]o rw h e nr e p e a t e de p i s o d e so fc l i n i c a l
mastitis are observed in a single lactation [118].
As for K. pneumoniae, looking for mastitis-causing
Strep. uberis in the environment is like looking for the
proverbial “needle in a hay stack”. Only 2 molecular
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Figure 2 Frequency distribution of sequence types (ST) of Streptococcus
agalactiae isolates from bulk tank milk originating from 111 dairy farms
in Denmark, 2009, showing predominance of ST1, ST23 and ST103
J Mammary Gland Biol Neoplasia (2011) 16:357–372 363epidemiological studies of Strep. uberis in the dairy
environment have been reported [110, 219]. Most environ-
mental samples (87%) contain multiple Strep. uberis
strains, with an average of 2.5 strains per sample based
on ribotyping of 4 isolates per sample [219]. Heterogeneity
of Strep. uberis is higher in soil samples than in fecal
samples, and as many as 20 isolates per soil sample may
need to be typed to find all strains that are present in the
sample [45]. When comparing the strain distribution
between environmental, fecal and milk isolates, many
strains can be found in multiple sample types, and some
strains are more common than others in environmental
samples [110, 219]. These observations raise the possibility
that the presence of a single strain in multiple quarters or
cows in a herd may be due to exposure to a strain that is
predominant in the environment, rather than to cow-to-cow
transmission, which is the mechanism that is usually
postulated.
The outcome of experimental challenge or natural
infection with Strep. uberis may range from severe
clinical disease to asymptomatic infection or even failure
to establish infection [82, 193]. Several authors have tried
to correlate strains with clinical or epidemiological
characteristics such as persistence of infection, clinical
signs or elevation of leukocyte counts in milk. Some
studies support the existence of persistent strains [217]
whereas others do not, leading to the suggestion that cow-
factors rather than strains determine the duration of
infection [151]. Alternatively, it is possible that none of
the currently used molecular markers, which are largely
based on primer binding sites, restriction sites, or
sequences of housekeeping genes, are relevant indicators
for duration of infection. Similarly, some studies support
an association between strains and clinical signs or
leukocyte counts [145, 193], whereas others do not
[217]. The capsule gene hasA has been associated with
clinical mastitis in field studies [150] but challenge studies
with hasA deletion mutants demonstrated that the gene
itself is not needed to cause clinical signs [55]. These
results may potentially be explained by linkage of hasA to
other virulence genes [150].
Despite the heterogeneity of the Strep. uberis population,
3 CCs have been associated with specific origins and
manifestations [150, 193]. In the UK, CC5 is the most
common CC found in milk, whereas CC143 is the most
common CC in New Zealand. CC86 is found in Australia,
New Zealand and the UK and is less common than CC5 or
CC143 in all three countries. The prevalence of CC5 and
CC86 did not differ between isolates from the environment,
milk or body sites of cows in New Zealand. CC143 was
overrepresented among environmental isolates, and isolates
that have not been assigned to a CC were underrepresented
in the environment compared to milk samples [150]. CC5 is
predominantly associated with clinical mastitis, CC143
with subclinical mastitis and CC86 with latent infection,
i.e. presence of Strep. uberis without a discernable
inflammatory response [193]. These associations are not
absolute, because clinical Strep. uberis mastitis is common
among New Zealand dairy cattle despite the predominance
of CC143, and subclinical Strep. uberis mastitis is common
in the UK despite the predominance of CC5 [24, 118]. The
6-gene MLST scheme [218] has been used to identify STs
that were unique to a single sample or common to multiple
cows, herds or countries. Unique and common strains were
compared with Strep. uberis O140J using a whole genome
DNA microarray, with the aim to identify genetic elements
that might explain why some strains are more common than
others [104]. The microarray data showed that approxi-
mately 82.5% of the O140J genome can be considered core
genome. Four genomic regions, which appeared to have
arisen from LGT based on GC-content, were overrepre-
sented among putatively host-adapted strains, but none of
these elements were exclusive to one group of strains [104].
As for Strep. agalactiae, mobile genetic elements are
suggested to play a role in the evolution and niche
adaptation of Strep. uberis, but their role in Strep. uberis
evolution seems limited compared to other Pyogenes group
streptococci [35, 73, 162, 205]. A wide range of virulence
genes may be present in Strep. uberis in a variety of
combinations [158]. So far, no single set of virulence
markers explains the different clinical and epidemiological
manifestations of Strep. uberis mastitis. It seems reasonable
to conclude that Strep. uberis is primarily an opportunistic
environmental pathogen [205], and that it may show
enhanced cow-to-cow transmission in some herds, possibly
due to acquisition of MGEs that confer a survival or
transmission advantage and possibly due to lapses in herd
management.
Streptococcus dysgalactiae
The epidemiology of Strep. dysgalactiae subsp. dysgalac-
tiae is poorly understood. It has been described as a
contagious pathogen [60] and as an environmental patho-
gen [178], but environmental sources have not been
investigated. Evidence for the dual nature of this pathogen
comes from intervention studies conducted in the 1960s
[132] and from molecular studies conducted in the 1990s.
RAPD-typing was used to explore the persistence of Strep.
dysgalactiae over the dry period [137]. Results from this
study, which covered 12 quarters from 6 cows, illustrate a
number of features of Strep. dysgalactiae. First, infections
may be transient or persistent. Second, one strain seems to
dominate within the herd. Finally, when multiple quarters
are positive simultaneously, this is usually caused by a
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sion. In a nutshell, and with all the caveats appropriate for a
single study with a limited number of cows, these patterns
describe a mixture of what one would expect for typical
contagious pathogens (persistent infections, dominant
strain) and typical environmental pathogens (transient
infections, multitude of strains). To date, all molecular
epidemiological studies of Strep. dysgalactiae have yielded
results that fit with a mixed contagious-environmental
epidemiology. Baseggio and colleagues [11] conducted
PFGE of 13 isolates from 8 herds in Australia and
confirmed that shared and unique strains co-exist within
herds. Gillespie and colleagues [67] used RAPD-typing to
examine 116 isolates from 3 herds in the USA. Multiple
strains were identified (n=17), but the majority of isolates
(73%) belonged to one of two RAPD-types. One type was
found in all 3 herds and was the most common type in two
of them. The other type was found in 2 herds and
predominated in one of them. Wang and coworkers [203]
showed that in each of 3 herds they investigated, most or all
of the infections were caused by the same strain, leading
them to emphasize the likely importance of cow-to-cow
transmission. The presence of the same predominant type in
multiple herds [67, 203] raises the possibility of niche-
adaptation of a specific subset of the Strep. dysgalactiae
population, although alternative explanations such as
contacts between farms could also be considered. Some-
what puzzling is Oliver’s observation that cows tend to be
positive for a single strain, which may appear in multiple
quarters at quite distant time points (1998). Variable
shedding of intramammary pathogens with a succession of
culture-negative and culture-positive results has been
described for Staph. aureus [172] but not for Strep.
dysgalactiae and further investigation of this phenomenon
may be warranted. By contrast, in an Australian study of 12
cows from 5 herds, persistence with continuous shedding
seemed to be the standard [203]. After a gap of about
10 years, new studies on Strep. dysgalactiae mastitis are
starting to appear. As discussed for Strep. agalactiae and
Strep. uberis, mobile genetic elements may act as a vehicle
for LGT between streptococcal strains and species, includ-
ing transfer of virulence genes and antimicrobial resistance
genes [73, 156]. The lactose-operon that is shared by Strep.
agalactiae and Strep. dysgalactiae subsp. dysgalactiae
could constitute a major survival advantage in the bovine
mammary gland [162]. Strep. dysgalactiae subsp. dysga-
lactiae also shares genes with Strep. pyogenes and Strept.
equi subsp. zooepidemicus, Strep. uberis and Strep. suis
[156, 157, 185]. Population level studies to link clinical,
epidemiological and genomic observations are lacking for
Strep. dysgalactiae subsp. dysgalactiae. As stated by Wang
and coworkers in [203] and still true today, “more work is
required”.
Other Streptococci, Enterococci and Lactococci
Other streptococci that are occasionally associated with
bovine mastitis include Strep. equi subsp. zooepidemicus
(SEZ; [50]) and Strep. canis [32, 75, 191]. Based on PFGE
[75] or automated ribotyping [191], outbreaks of Strep.
canis mastitis were due to a single strain of Strep. canis
within a herd. In one case, circumstantial evidence was
used to identify a cat with chronic sinusitis as the most
likely source of infection [191]. Signs of infection in the cat
predated signs of infection in the cows, and the cat had
access to cows. Because interspecies transmission of Strep.
canis is relatively rare, and because herd management was
permissive to contagious transmission of mastitis patho-
gens, a single transmission event from cat to cow followed
by cow-to-cow transmission was considered more likely
than the cat acting as a point source for each individual cow
[191]. This study exemplifies how molecular data need to
be combined with other types of epidemiological data to
infer transmission routes. Molecular epidemiological studies
of bovine mastitis caused by SEZ have not been reported but
in a recent SEZ-mastitis outbreak in goats, attempts were
made to determine whether horses that were co-grazed with
the goats could be identified as source of the outbreak [148].
As for the Strep. canis outbreaks, a single strain was
associated with the SEZ outbreak. The mastitis-causing
strain of SEZ, however, could not be identified in horses. It
is possible that the goats contracted SEZ from elsewhere but
failure to detect the outbreak strain in the horses was
attributed to a delay in sampling of the horses relative to
the mastitis outbreak, and to the heterogeneity of SEZ strains
in equine feces [148].
In bovine mastitis diagnostics, streptococci are often
grouped with other genera such as enterococci and
lactococci. Because phenotyping is generally used for
species identification, even though it is unreliable [87],
limited information is available on the exact contribution of
Enterococcus or Lactococcus species to mastitis. Strain
typing studies of these organisms are almost no-existent.
Petersson-Wolfeandcolleagues[144] showed that enterococci
from bovine mastitis were genetically diverse, in agreement
with their probable origin from feces, as implied in the names
of some of the most common species associated with mastitis:
E. faecalis and E. faecium.
Staphylococcus Aureus
Staphylococcus aureus is a commensal and pathogen of
humans and several animal species, including cattle. In
women, Staph. aureus is among the most common
etiological agents of bacterial mastitis but human staphylo-
coccal mastitis has not been extensively studied, unlike
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[36]. By contrast, Staph. aureus is possibly the most studied
mastitis pathogen in dairy cattle. Due in part to its
importance as a human pathogen, many typing methods
have been used or developed for Staph. aureus including,
but not limited to, ribotyping, RAPD-typing, PFGE, MLST,
spa-typing, coagulase gene RFLP (restriction fragment
length polymorphism), MLVA, micro-arrays and whole
genome comparisons [57, 80, 88, 178, 182]. More than
for any other pathogen described in this paper, this section
can only be a summary of the main findings from molecular
epidemiological studies. Major themes include the mode of
transmission, sources, strain-specific clinical or epidemiological
manifestations and host association.
Based on epidemiological studies and mastitis control
efforts, Staph. aureus has been classified as a contagious
pathogen [60]. This classification is supported by molecular
data, which show that in most herds with Staph. aureus
mastitis, a single strain affects multiple cows and is often
the most prevalent strain [7, 124, 188, 214]. Transmission is
thought to occur primarily via the milking machine, udder
cloths or milkers’ hands. Molecular typing also supports a
role of flies in transmission of Staph. aureus between
animals [31, 68]. Successful control of Staph. aureus
mastitis has been described [85, 178, 215], but prevention
of cow-to-cow transmission often fails to eliminate the
problem from dairy herds. Commonly used explanations for
disappointing results from control efforts include false-
negative results from bacteriological culture, resulting in
undetected cases that may re-infect the rest of the herd, and
the poor response of Staph. aureus mastitis to treatment
[10]. Molecular studies offer an additional explanation. In
most herds, numerous strains with low prevalence or
incidence can be found in addition to one or a few high-
prevalence strains [7, 31, 79, 106, 124, 188, 214]. Presence
of multiple strains proves that not all infections are the
result of cow-to-cow transmission and in some herds,
Staph. aureus mastitis shows the molecular epidemiology
and management response of an environmental pathogen
[178, 215]. In exceptional cases, as many as 5 different
strains have been isolated from milk of a single animal over
time [178], a pattern that is thought to be unique to
environmental pathogens. The number of strains per herd is
higher on farms that purchase animals than in closed herds
[79, 123]. Extramammary sources of Staph. aureus include
cows’ skin and body sites and the farm environment, e.g.
bedding materials, insects, people, non-bovine animals,
feedstuffs and air [31, 163]. One study showed that milking
equipment may play a role in cow-to-cow transmission of
strains from milk or teat skin, and that milk and teat skin
contain distinct populations of Staph. aureus [216]. By
contrast, Haveri and colleagues [79] found the same strains
in milk, on teat skin, on milking equipment and milkers’
hands. Only one strain showed a slightly higher prevalence
among skin isolates than in milk samples. A third study
[31] occupies an intermediate position, in that one
predominant strain was shared between milk and body
sites in most herds, in agreement with results from Haveri
et al. [79], whereas a second strain was predominantly or
exclusively found in milk or body sites only, in agreement
with results from Zadoks et al. [216]. Similarity of strains
from milk and skin was documented in studies on a small
number of herds that were selected on the basis of Staph.
aureus mastitis problems, whereas the difference between
milk and skin strains was observed in a cross-sectional study
of a large number of herds [31, 79, 216]. Strain distribution
is herd-specific [31], so study design and herd selection may
explain some of the discrepant results. Strains from milk and
skin can both be found in the barn environment [31]. Among
body sites, hock skin was specifically identified as a
common site for colonization with milk- or skin-associated
strains of Staph. aureus [31]. Some authors see extramam-
mary presence of Staph. aureus as a potential source of
intramammary infections but others favor the opinion that
intramammary infection results in contamination of extra-
mammary sites [31, 79].
Whereas Strep. agalactiae is generally easily controlled
and E. coli populations are too heterogeneous to warrant
investigation of strain-specific characteristics, the balance
of strain predominance and heterogeneity in Staph. aureus
is such that considerable effort has been invested in
identification of strain specific outcomes of infection. This
has led to demonstration of strain-specific associations with
somatic cell count [39, 195, 214], milk yield [121], biofilm
production [61], clinical signs [77, 214], persistence [78]
and treatment response [39, 70, 195]. Not all studies
support an association between clinical outcome and strain
[106, 121, 124]. In some studies, the existence of an
association depended on the typing method, treatment
product or clinical parameter used [39, 78, 221]. Strain-
specific differences in transmissibility have also been
documented [70, 106, 122]. Some authors suggest that
molecular markers of the likelihood of transmission or cure
should be incorporated into diagnostic protocols [10, 70].
Apart from the blaZ gene for penicillin resistance, markers
are currently not sufficiently standardized to be imple-
mented routinely. Many staphylococcal enterotoxin genes
can be present in bovine Staph. aureus, including staphy-
lococcal enterotoxins (SE) A through D, G through O and
U, toxic shock syndrome toxin (TSST) and exfoliative
toxins A and B [78]. Presence of the combination of SEC/
TSST is common in bovine Staph. aureus in many areas
[58, 59, 131, 192] but virulence gene profiles are very
heterogeneous and differ between regions and countries
[78, 107, 202]. Staphylococcal enterotoxins may be
relevant to human health because of their role in food
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syndrome but they are not essential for the pathogenesis
of bovine mastitis [106, 107].
Using comparative methods, predominance of strains
within and across herds was recognized [57, 59, 106, 216].
It was also shown that, as for Strep. agalactiae, human and
bovine Staph. aureus are largely distinct populations [106,
170]. Comparison across herds, countries, and host-species
became much easier after the introduction of MLST [51].
This led to identification of STs and CCS that were found
exclusively in animals, predominantly in humans, or across
a wide range of host species [176, 182, 197]. Some STs can
be found in cattle, goats and sheep, e.g. ST133 and ST126
[153, 176]. Other STs are limited to goats or cattle only, e.g.
ST703 and ST151, respectively [176]. On-line databases
can be skewed by underreporting if only type strains are
entered in the database or by over-reporting of herd specific
strains [175, 195]. Based on publications, the most common
CC in bovine mastitis across herds and countries are
associated with ST97, ST126, ST133, ST151, ST479 and
ST771 [2, 76, 88, 153, 166, 174, 176, 182, 195]. The list of
studies may appear long, but correlation of findings from
different research groups would be facilitated if more
groups included MLST in their typing protocols. Identifi-
cation of host-associated lineages has led to the search for
molecular correlates of host specialization [80]. Although
lineage- and host-specific genes have been identified, many
human and animal Staph. aureus strains are genetically
quite similar [182]. Bovine strains are heterogeneous in
content and no gene or open reading frame is uniformly
shared by all bovine Staph. aureus strains [13, 101, 198].
LGT may contribute to the emergence of animal-pathogenic
strains from human strains, and vice versa [72, 111].
Several STs have been associated with bovine mastitis as
well as human colonization or infection, e.g. ST1, ST8,
ST9, ST79 and methicillin susceptible or methicillin
resistant ST398 [176, 195, 197]. In some instances, there
is evidence of humans and cattle sharing the same strain of
Staph. aureus through direct contact [95, 106, 170]. Of
more concern is the emergence of supposed bovine-adapted
strains such as ST130 or ST151 in the human population
[65] and emergence of supposed human-adapted strains
such as ST8 and ST20 as common strains in the cattle
population [166]. This is particularly worrisome in the case
of methicillin resistant Staph. aureus [65]. If human and
bovine strains develop the ability to spread with equal ease
in both host populations, zoonotic risks and the implications
of antimicrobial resistance will become much greater than
they are today.
Coagulase Negative Staphylococci
Coagulase negative staphylococci (CoNS) are a heteroge-
neous group of organisms with limited but non-negligible
impact on udder health and productivity [171, 186]. For
many years, CoNS were identified to the species level using
phenotypic methods. Such methods are unreliable for
bovine isolates, partly because most phenotypic assays
were developed for applications in human medicine whilst
some of the most common CoNS of cattle, such as Staph.
chromogenes, very rarely occur in humans [168, 213]. To
allow for study of the impact of individual CoNS species on
mammary gland health, accurate species identification of
large numbers of CoNS isolates is needed. The usefulness
of numerous molecular methods for this purpose has been
evaluated, including PCR-RFLP of the gapC gene [140],
tRNA intergenic spacer PCR [184], amplified fragment
Table 1 Strain level molecular epidemiological studies of coagulase negative staphylococci from bovine milk and extra mammary sources
Species identification
method
Strain typing
method
Target species
(number of isolates)
Epidemiological comparison Reference
API staph system PFGE S. chromogenes (66) Within-herd: heterogeneity of CoNS populations [69]
S. epidermidis (37)
S. hyicus (38)
S. simulans (10)
S. warneri (7)
VITEK PFGE S. chromogenes (27) Within-cow: Persistence over dry cow period [154]
S. warneri (2)
S. xylosus (5)
API staph system PFGE S. epidermidis (36) Within-herd: Clonality of strains with antimicrobial resistance [169]
API staph, ribotyping PFGE S. chromogenes (46) Within-herd: heterogeneity in milk, bovine body sites and humans [187]
S. epidermidis (4)
S. simulans (21)
Conventional methods PFGE S. epidermidis (200) Between host: Comparison of human and bovine strains [190]
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[25] and sequencing of the housekeeping genes 16s rDNA
[140], tuf [30], and rpoB[ 168]. The distribution of species
in milk samples and the environment has been compared,
which has led to a tentative classification of species as cow-
associated (e.g.Staph. chromogenes and Staph. epidermidis),
opportunistic (e.g. Staph. haemolyticus and Staph. simulans),
and environmental (e.g. Staph. equorum and Staph. xylosus;
[147]). Despite the flurry of molecular studies at the species
level, strain typing studies to explore the environmental or
contagious nature of CoNS mastitis in a manner similar to
that described for Staph. aureus and Streptococci are rare.
The molecular epidemiology of some of the most common
CoNS species has been explored by means of PFGE
(Table 1). Surprisingly, most of the bovine CoNS strain
typing studies did not use molecular methods for species
identification (Table 1).
Thorberg and colleagues [190] used 105 epidemiologi-
cally unrelated human and bovine isolates to establish that
PFGE has excellent discriminatory power for typing of
Staph. epidermidis. Subsequently, they investigated 2 herds
in detail and demonstrated dominance of one or two types
in each herd. The dominant types from milk were also
isolated from skin of the people that milked the cows.
Because isolation of Staph. epidermidis from human skin is
more common than isolation from bovine skin, the authors
conclude that humans are probably the main source of
infection for cows [190]. The Staph. epidermidis population
from bovine milk was much more heterogeneous in a study
by Gillespie and coworkers [69], who identified 21 PFGE
patterns among 37 isolates of 29 cows. Only 5 PFGE-types
were shared by multiple cows in a herd, with a maximum of
5 cows per strain. The majority of strains were unique to a
single cow. Antimicrobial resistance may contribute to
clonal dissemination of Staph. epidermidis strains. Three of
5 multidrug resistant (MDR) strains were identified in
multiple cows whereas only 2 of 17 non-MDR strains were
identified in multiple cows [69, 169]. For Staph. chromo-
genes, considerable within-herd heterogeneity was observed
based on AFLP and PFGE [69, 154, 187]. The heterogeneity
of Staph. chromogenes is surprising because it suggests
existence of environmental reservoirs. In one study, cows’
body sites and milkers’ hands were identified as a source of
Staph. chromogenes [187], but other attempts to identify
extra mammary reservoirs have been unsuccessful [147].
When multiple Staph. chromogenes isolates are obtained
from a single quarter during lactation or before and after the
dry period, this may be due to the same strain, suggesting
persistence of infection, or to different strains, suggesting
cure and re-infection [69, 154]. Similarly, Staph. hyicus
infections may or may not persist over the dry period. In
lactation, Staph. hyicus infection can last up to 10 months
[69]. In theory, this could create a window of opportunity for
contagious transmission but occurrence of the same strain in
multiple cows or herds is rare [69]. Molecular data support
the possibility that Staph. simulans could be cow-associated,
and yet this species has also been classed as opportunistic
[147, 187]. Data for other species are too sparse to allow for
meaningful interpretation. Figure 3 illustrates the heteroge-
neity of staphylococcal species and strains that may be
found within an animal. Given the level of within-herd and
even within-cow heterogeneity of CoNS species and
strains, strain typing will be essential for detailed studies
of transmission, persistence and cure of CoNS infections in
dairy cattle.
Other Mastitis Pathogens: Prototheca and Mycoplasma
Molecular methods for species-level identification have
been developed for several other genera of mastitis
pathogens, including Prototheca, a group of yeast-like
micro-algae that have been described as a cause of mastitis
in Japan [139], Europe [5, 89, 160] and North and South
America [6, 28]. Several methods have been used for
identification of species and subspecies genotypes of
Prototheca. Genotype-specific PCR and RFLP and 18S
rDNA sequence analysis are used to identify P. zopfii
genotype 1 and genotype 2 and P. blaschkae, formerly
Figure 3 Pulsed field gel electrophoresis results for staphylococci
from teat skin (TS), prepartum secretion (PS) and early lactation milk
(M) of a single animal. Lanes 1 and 12 contain molecular markers
(MM); Lane 2 and 3 represent Staphylococcus devriesei (Sd) from the
left rear (LR) mammary quarter; Lanes 4 to 8 represent Staph.
chromogenes (Sc) from the right rear (RR) and right front (RF)
quarters; Lanes 9 to 11 represent Staph. aureus (Sa) from the right
front quarter. One strain of Staph. devriesei, four strains of Staph.
chromognes and two strains of Staph. aureus can be seen (Ringen and
Middleton, unpublished data)
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can identify P. zopfii genotype 2, P. blaschkae and P.
wickerhamii [161]. When combined with DNA resolution
melting analysis (qPCR/RMA), real-time PCR also allows
for identification P. zopfii genotype 1, P. stagnora and P.
ulmea [161]. Prototheca zopfii genotype 2 is the most
common genotype in milk (Table 2). Some authors suggest
that this indicates increased ability to cause mastitis because
P. zopfii genotype 2 is rare in the environment compared to
P. zopfii genotype 1 [139]. Other authors find P. zopfii
genotype 2 as the most common genotype in milk as well
as the environment [160]. Development of additional
molecular methods, especially at the subspecies level, may
aid in studies of the epidemiology of Prototheca mastitis.
Mycoplasma spp. are mollicutes, cell wall-less, slow
growing organisms that require special culture media and
growth conditions. For Mycoplasma spp., as for Prototheca
spp., many molecular studies focus on detection and species
identification, especially because molecular diagnostics are
faster than culture [8, 81, 164, 165]. As for other bacterial
mastitis pathogens, outbreak investigations and routes of
transmission are the main subjects of molecular epidemio-
logical studies. In contrast to most other mastitis pathogens,
Mycoplasma spp. may affect multiple organ systems.
Asymptomatic carriage in the ears and respiratory tract
has been described, as well as otitis, pneumonia and
arthritis, primarily in calves, and mastitis in prepubertal
calves and adult cattle [61–63, 116]. The occurrence of
various non-clinical and clinical manifestations adds new
angles to Mycoplasma transmission studies because multi-
ple age groups, carrier states and disease syndromes may
act as source for mastitis outbreaks [152]. In addition,
dissemination of the pathogen within the individual host,
probably via hematogenous or lymphatic spread, may occur
[61, 62]. The molecular epidemiology of respiratory M.
bovis has been investigated with AFLP, PFGE and RAPD
typing [116]. AFLP [102], PFGE [14] and restriction
enzyme analysis (REA) [40] have been used to study the
molecular epidemiology of mastitis-associated Mycoplasma
spp., including M. bovis, M. californicum and Mycoplasma
sp. bovine group 7. Within individual animals, multiple
strains of the same Mycoplasma species can be found at
different body sites or even within the mammary gland [14,
63, 102]. In most instances, however, M. bovis or M.
californicum isolates found in milk, udder parenchyma and
supramammary lymph nodes belong to the same PFGE
type [14]. Furthermore, 90% of isolates from eyes, ears,
feces, joints, the urogenital system and internal organs
belong to the same PFGE type as the mammary strains
[14], which could be explained by hematogenous spread. In
the respiratory tract, only 40% of isolates belonged to
PFGE types found in the mammary system and the rest of
the body [14]. Mycoplasma is more heterogeneous in the
respiratory tract and it is also found more commonly in the
nose than other body sites [152]. Thus, it seems likely that
colonization of the respiratory tract by a heterogeneous
Mycoplasma population is occasionally followed by sys-
temic dissemination of one or a few strains. Mycoplasma
spp. may be transmitted vertically from dam to calf or
horizontally via nasal discharge or from cow to cow at
milking [40, 63]. Transmission and dissemination of
Mycoplasma via extra mammary routes explains why
control of Mycoplasma mastitis can fail when it is solely
based on detection of intramammary infections and pre-
vention of cow-to-cow transmission at milking [61, 62]. In
Australia, Mycoplasma sp. bovine group 7, a member of the
M. mycoides cluster, has been associated with mastitis. An
REA-based study of 24 epidemiologically related strains
and 36 epidemiologically unrelated strains from multiple
herds, countries and continents showed that all epidemio-
logically related isolates belonged to the same strain,
whereas 28 different strains were detected among 32
unrelated isolates [40]. REA did not have perfect type-
ability, but it did show good discriminatory power and
excellent epidemiological concordance [180]. Without
demonstration of discriminatory power, homogeneity of
strains within an outbreak would not have been epidemi-
ologically meaningful. As in the studies of M. bovis,
multiple organs within an individual animal and multiple
animals within a herd were infected by the same strain. This
included calves, cows and aborted fetuses [40]. Both M.
bovis and Mycoplasma sp. bovine group 7 may persist in a
Table 2 Distribution of Prototheca isolates from milk and environmental samples over species and genotypes
Country Milk Environment Reference
P. zopfii 1 P. zopfii 2 P. blaschkae P. zopfii 1 P. zopfii 2 P. blaschkae
Japan 0 67 0 29 3 0 [139]
Germany 2 177 21 n.t. n.t. n.t. [5]
Poland 0 43 1 n.t. n.t n.t. [89]
Italy 0 105 3 0 45 8 [160]
n.t. not tested
J Mammary Gland Biol Neoplasia (2011) 16:357–372 369herd for a long time, with documented persistence of a year
and 18 months, respectively [40, 152]. Regional persistence
of Mycoplasma strains for even longer periods may also
occur. In Denmark, a single AFLP type was responsible for
2 cases of calf pneumonia and 2 multi-herd outbreaks of M.
bovis mastitis. The cases of pneumoniae were detected at
intervals of 10 years (1981 and 1991) in one region. The
multi-herd outbreaks of mastitis occurred in 1984 and 1986/
7 in two different regions [102]. The suggestion was made
that the first pneumonia isolate gave rise to the first mastitis
outbreak, which then led to the second mastitis outbreak.
Contact between farms could have occurred via purchase of
colonized or infected animals, attendance at animal shows
or cross-contamination by service personnel visiting multi-
ple farms [102]. The same report describes that M. bovis
isolates obtained in the 1990s showed greater heterogeneity
than those from the 1980s. Strains from the 1990s were
primarily obtained from lung samples whereas strains from
1980 were largely obtained from mammary glands. It is
unclear whether heterogeneity is associated with the
different decades or the different organ systems. Consider-
ing that lung isolates were more heterogeneous than
mastitis isolates, one could argue that the mastitis strain
was particularly well suited to survival in the bovine
mammary gland and that homogeneity indicated host
adaptation of the strain rather than epidemiological con-
nections between farms. As in many situations, this
example illustrates that one has to be careful with
interpretation of molecular data and that epidemiological
data must be taken into consideration to identify and
differentiate possible and likely scenarios [212]. The recent
publication of the complete genome of M. bovis type strain
PG45 [209] and the emergence of Mycoplasma mastitis in
multiple countries [135] can be expected to lead to
development of additional typing methods and to further
studies of the epidemiology, pathogenesis and control of
Mycoplasma mastitis. Given that MLST has already been
developed for M. agalactiae, a mastitis pathogen of sheep
and goats, and for M. hyopneumoniae, it seems only a
matter of time until an MLST scheme for M. bovis is
published [114, 117].
Summary and Outlook
Molecular epidemiological studies have not changed the
biology of mastitis and despite decades of research, mastitis
control in dairy herds still largely depends on conscientious
and continuous effort on the part of the farmer or herd
manager and his or her staff. Molecular epidemiological
studies have, however, contributed considerably to our
understanding of sources, transmission routes, and progno-
ses for many mastitis pathogens, which helps dairy farmers
to focus their efforts in those areas most relevant to mastitis
prevention and control. Molecular studies also contribute to
an understanding of mechanisms of host-adaptation and
disease causation, providing insight into pathogen evolu-
tion, potential targets for development of therapeutics or
vaccines, and the risk of exchange of genetic elements or
pathogens between bacterial species and host species.
Molecular epidemiological studies will also be of value
for understanding of mastitis in non-bovine host species,
including sheep and goats. Many molecular epidemiolog-
ical studies have been based on use of selected targets in the
genome, giving rise to banding patterns based on
restriction- or primer binding sites, or to allelic profiles
for housekeeping or virulence genes. Such studies continue
to be useful diagnostic tools when the aim is to understand
pathogen sources and transmission mechanisms or to
measure strain-specific clinical outcomes such as duration,
severity and cure. The molecular epidemiology of mastitis
has now moved into the genomics era, with whole genome
sequencing completed for the major gram-positive patho-
gens and in progress for several gram-negative pathogens.
Results from genomic studies and integration with other “-
omics” such as host genomics, transcriptomics, proteomics
and metabolomics, will give us yet more detailed under-
standing of the biology of mastitis. Years ago, Achtman [1]
complained of “a surfeit of YATMs” (yet another typing
method). The challenge for mastitis researchers is to avoid
“a surfeit of YATSs” (yet another typing study) and to use
molecular biology tools to generate a deeper understanding
of mastitis epidemiology. The tools are available. Let’s
hope we manage to ask the right questions.
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